<DOC>
	<DOCNO>NCT00562549</DOCNO>
	<brief_summary>The purpose determine effective dosage study effect dosage take 12 day systolic diastolic blood pressure patient hypertension .</brief_summary>
	<brief_title>Safety Effects SLx-2101 Taken 14 Days Blood Pressure Patients With Hypertension</brief_title>
	<detailed_description>1 . Office seat peripheral systolic diastolic blood pressure 2 . Adverse event vital sign 3 . Plasma concentration SLx-2101</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<criteria>Male female 18 80 year , inclusive Moderate severe hypertension Body weight within body mass index range 18 32 kg/m2 Subject receive four antihypertensive agent History drug abuse Exposure new chemical entity within 3 month prior first day dose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>